logo
#

Latest news with #Exo

TRON: Catalyst (PC) Review
TRON: Catalyst (PC) Review

Yahoo

time3 days ago

  • Entertainment
  • Yahoo

TRON: Catalyst (PC) Review

When I first tried TRON: Catalyst, I was pretty happy with what I had experienced. Although my initial preview was only a vertical slice within the city of Vertical Slice, the game introduced enough good ideas that I was eager to get my hands on a much more extensive play session. My time with TRON: Catalyst has been somewhat of a mixed experience. On the one hand, I really admire what both Bithell and the game itself are trying to do here. However, the game really needed to iron out some kinks to create a really amazing game, and it doesn't really look like they have. I talked about it a bit during my preview, but I'll reiterate it here. Players take on the role of Exo—a simple Courier program who is caught in a massive explosion during a routine delivery. Little did she know, the explosion was caused by a Glitch Catalyst, which distorts her code and gives her the ability to rewind time back to key loop points, allowing her to use abilities and knowledge gained to outsmart and outmaneuver her opponents. This sets off a chain of events that will lead to who decides the fate of Vertical Slice city as Exo fights against Core—the city's malevolent rulers—and a ruthless program named Conn, who pursues her throughout the Arq Grid. While I mentioned how much I liked how the game weaved its gameplay concepts into its narrative, one thing I didn't mention was how much I appreciate the game's protagonist. Since TRON: Catalyst is set somewhere before the events of TRON: Legacy, Exo isn't just a regular program, but an Iso—Isomoprhic Algorithms that were created from nothing in Flynn's Grid. This allows not just the story to maintain the themes of race politics that were present in the film, but it also gives our protagonist a lot more agency and identity. She has the freedom to be whatever she wants to be, and allowing her to manipulate not just her own code, but the systems around her gives the game a lot of depth and nuance that isn't made immediately present in the writing. Not only that, I really liked how TRON: Catalyst is somewhat of a sequel to TRON: Identity, as characters and factions that were established in that game find their way into this one. Gameplay is where TRON: Catalyst leaves something to be desired. Initially, I said the game was 'Surprisingly simple,' and honestly, I feel that works both for and against the game. On the one hand, it makes it so it's not hard to get into, and gives players a lot of freedom to get good at it. On the other hand, it's never particularly challenging or as cool as something with the TRON license could be. The biggest place this exists is in the combat. While it works well enough, giving players a pretty straightforward way to engage enemies both with their Discs and in Lightcycle chases, it always feels a little basic and by the numbers. It doesn't have the sense of fluidity or cool that was present in TRON: Evolution. When it works, it can be pretty enjoyable, but I think longtime TRON fans like myself might be left wanting for a bit more. Not only that, but since TRON: Catalyst doesn't reward players with traditional experience—like I mentioned in my preview—it feels like some pretty basic moves like reflecting enemy Discs are locked behind a fairly restrictive wall. And while you do get a lot of cool new abilities as the story progresses, it could've made accessing the more basic ones a bit easier. Also, and this might just be a me thing, the game really could've done with a better trajectory line, particularly for bouncing your Disc off walls to hit enemies. This is why TRON: Catalyst probably exists best as a smaller experience better suited to something like the Nintendo Switch. It creates the sense of a world that is technically small but feels big, and it's so rich with TRON lore and its world feels so genuinely realized that it's definitely worth experiencing, but in a more relaxed, second-screen kind of way. Where TRON: Catalyst really stands out is in its visuals. The sleek, techno-cool aesthetic of TRON: Legacy is captured in an incredibly detailed and authentic way, and you can see the love and care put into the environment in every area you walk into. The music is appropriately matched. Dan Le Sac did an excellent job capturing the vibe of Daft Punk's soundtrack for TRON: Legacy, but putting his own unique touch on it for something that sounds genuinely his but uniquely TRON. Honestly, I know this review probably sounded more negative than I wanted it to, but I think there is a lot to like about TRON: Catalyst. Like I said in my preview, Bithell stepped a bit outside their comfort zone and took a big chance, and for the most part, I think it paid off. While I wished it had a little bit more, I really loved what was there, and I think a lot of TRON fans will too.

Exo Launches a New Era in Disease Diagnosis with the First FDA-cleared Ultrasound AI for Detection of Pleural Effusion and Consolidation/Atelectasis
Exo Launches a New Era in Disease Diagnosis with the First FDA-cleared Ultrasound AI for Detection of Pleural Effusion and Consolidation/Atelectasis

Yahoo

time3 days ago

  • Health
  • Yahoo

Exo Launches a New Era in Disease Diagnosis with the First FDA-cleared Ultrasound AI for Detection of Pleural Effusion and Consolidation/Atelectasis

Exo Iris® now automatically detects and localizes key pulmonary findings for emergency care, showing superiority to clinicians alone SANTA CLARA, Calif., June 18, 2025--(BUSINESS WIRE)--Exo (pronounced "echo"), the leader in AI-powered, accessible medical imaging, is transforming lung disease diagnosis with another first. Now included on Exo Iris® is the first ever FDA 510(k) cleared AI for detecting pleural effusion and consolidation/atelectasis. These on-device real-time indicators empower clinicians with objective data to help detect lung diseases like pneumonia and tuberculosis at the bedside in seconds. Arun Nagdev, MD, Vice President of Clinical Affairs at Exo and a leading POCUS expert, said, "This groundbreaking real-time AI provides a remarkable assist for all clinicians at the bedside, instantly and accurately detecting fluid around the lungs or areas of collapsed lung, key markers for significant infections like pneumonia or tuberculosis. This is a great support for clinicians looking to diagnose commonly presenting patient symptoms of shortness of breath, coughing, pain, and fatigue." Said Dornoosh Zonoobi, VP of AI at Exo, "Validated in rigorous clinical studies, these AIs enabled clinicians to detect key lung findings, with sensitivity and specificity in the 'excellent' range. We're thrilled to bring these FDA-cleared firsts to all clinicians and to meaningfully impact patient diagnosis and outcomes when it matters most." These clearances mark not only a technical and regulatory milestone, but a meaningful expansion in how Exo is supporting frontline providers and patients when every second counts. Exo remains focused on delivering technology that enables critical decisions instantly, intelligently, and saves lives at scale. These clearances bring to a remarkable 14, the FDA-cleared AI indicators embedded in Iris. This sweeping portfolio is unmatched in handheld ultrasound today. All commercialized Exo AI runs directly on Exo Iris®, operates without internet, eliminates lag, and enables expert-level diagnostics in any setting. Exo is establishing a new standard in fast, accurate, and scalable point-of-care imaging. Visit Exo's website to explore these capabilities. About Exo Exo is redefining medical imaging with its advanced ultrasound platform, combining novel silicon-based hardware, tightly coupled AI, and easy-to-use collaboration software. Its handheld and soon-to-be OEM-integrated systems deliver high-performance imaging and real-time clinical intelligence, driving better, more accessible diagnostics and outcomes across diverse care settings. Follow us at @exoeffect on X, LinkedIn, Facebook, and Instagram. View source version on Contacts media@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Exo Launches a New Era in Disease Diagnosis with the First FDA-cleared Ultrasound AI for Detection of Pleural Effusion and Consolidation/Atelectasis
Exo Launches a New Era in Disease Diagnosis with the First FDA-cleared Ultrasound AI for Detection of Pleural Effusion and Consolidation/Atelectasis

Business Wire

time3 days ago

  • Health
  • Business Wire

Exo Launches a New Era in Disease Diagnosis with the First FDA-cleared Ultrasound AI for Detection of Pleural Effusion and Consolidation/Atelectasis

SANTA CLARA, Calif.--(BUSINESS WIRE)--Exo (pronounced 'echo'), the leader in AI-powered, accessible medical imaging, is transforming lung disease diagnosis with another first. Now included on Exo Iris® is the first ever FDA 510(k) cleared AI for detecting pleural effusion and consolidation/atelectasis. These on-device real-time indicators empower clinicians with objective data to help detect lung diseases like pneumonia and tuberculosis at the bedside in seconds. These clearances bring to a remarkable 14, the FDA-cleared AI indicators embedded in Iris. Exo AI runs directly on Exo Iris®, operates without internet, eliminates lag, and enables expert-level diagnostics in any setting. Share Arun Nagdev, MD, Vice President of Clinical Affairs at Exo and a leading POCUS expert, said, ' This groundbreaking real-time AI provides a remarkable assist for all clinicians at the bedside, instantly and accurately detecting fluid around the lungs or areas of collapsed lung, key markers for significant infections like pneumonia or tuberculosis. This is a great support for clinicians looking to diagnose commonly presenting patient symptoms of shortness of breath, coughing, pain, and fatigue.' Said Dornoosh Zonoobi, VP of AI at Exo, ' Validated in rigorous clinical studies, these AIs enabled clinicians to detect key lung findings, with sensitivity and specificity in the 'excellent' range. We're thrilled to bring these FDA-cleared firsts to all clinicians and to meaningfully impact patient diagnosis and outcomes when it matters most. ' These clearances mark not only a technical and regulatory milestone, but a meaningful expansion in how Exo is supporting frontline providers and patients when every second counts. Exo remains focused on delivering technology that enables critical decisions instantly, intelligently, and saves lives at scale. These clearances bring to a remarkable 14, the FDA-cleared AI indicators embedded in Iris. This sweeping portfolio is unmatched in handheld ultrasound today. All commercialized Exo AI runs directly on Exo Iris®, operates without internet, eliminates lag, and enables expert-level diagnostics in any setting. Exo is establishing a new standard in fast, accurate, and scalable point-of-care imaging. Visit Exo's website to explore these capabilities. About Exo Exo is redefining medical imaging with its advanced ultrasound platform, combining novel silicon-based hardware, tightly coupled AI, and easy-to-use collaboration software. Its handheld and soon-to-be OEM-integrated systems deliver high-performance imaging and real-time clinical intelligence, driving better, more accessible diagnostics and outcomes across diverse care settings. Follow us at @exoeffect on X, LinkedIn, Facebook, and Instagram.

Baekhyun 2025 World Tour Live in KL
Baekhyun 2025 World Tour Live in KL

The Sun

time3 days ago

  • Entertainment
  • The Sun

Baekhyun 2025 World Tour Live in KL

BYUN Baek-hyun, better known as Baekhyun, the main vocalist of popular K-pop group Exo is bringing his first-ever solo world tour to Malaysia. Organised by iMe Malaysia, the 2025 Baekhyun World Tour in Kuala Lumpur will take place on Saturday, Aug 23 at Idea Live KL. The tour, themed Reverie, reflects Baekhyun's wish to give fans an unforgettable, dreamlike experience, one where he and Exo-Ls can create new, lasting memories together. Known for his rich vocals, Baekhyun has left his mark as both a member of Exo and a successful solo artist. He has contributed to several drama soundtracks with emotional hits such as For You, Is It Me?, and Hello. In May 2025, he released his fifth mini album Essence of Reverie, building further excitement for this global tour. As the name suggests, the concert promises an enchanting blend of emotion, artistry and connection. The tour officially began with back-to-back shows at the KSPO Dome in Seoul earlier this month, marking the start of Baekhyun's solo journey across the world. He will visit 29 cities across Asia, the Americas, Europe, and Oceania including Tokyo, Manila, Jakarta, Bangkok, Taipei, Los Angeles, Mexico City, London, Paris, Melbourne, Singapore and more. Ticket prices range from RM398 to RM918 (excluding a RM4 processing fee). Each transaction is limited to two tickets only. For the latest updates, visit the organiser's official social media platforms.

Baekhyun to bring Reverie tour to KL this August
Baekhyun to bring Reverie tour to KL this August

The Sun

time3 days ago

  • Entertainment
  • The Sun

Baekhyun to bring Reverie tour to KL this August

BYUN Baek-hyun, better known as Baekhyun, the main vocalist of popular K-pop group Exo is bringing his first-ever solo world tour to Malaysia. Organised by iMe Malaysia, the 2025 Baekhyun World Tour in Kuala Lumpur will take place on Saturday, Aug 23 at Idea Live KL. The tour, themed Reverie, reflects Baekhyun's wish to give fans an unforgettable, dreamlike experience, one where he and Exo-Ls can create new, lasting memories together. Known for his rich vocals, Baekhyun has left his mark as both a member of Exo and a successful solo artist. He has contributed to several drama soundtracks with emotional hits such as For You, Is It Me?, and Hello. In May 2025, he released his fifth mini album Essence of Reverie, building further excitement for this global tour. As the name suggests, the concert promises an enchanting blend of emotion, artistry and connection. The tour officially began with back-to-back shows at the KSPO Dome in Seoul earlier this month, marking the start of Baekhyun's solo journey across the world. He will visit 29 cities across Asia, the Americas, Europe, and Oceania including Tokyo, Manila, Jakarta, Bangkok, Taipei, Los Angeles, Mexico City, London, Paris, Melbourne, Singapore and more. Ticket prices range from RM398 to RM918 (excluding a RM4 processing fee). Each transaction is limited to two tickets only. For the latest updates, visit the organiser's official social media platforms.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store